Poster Sessions
P1.01-016 Next-Generation Sequencing Shows Mechanisms of Intrinsic Resistance in ALK-Positive NSCLC Patients Treated with Crizotinib

https://doi.org/10.1016/j.jtho.2017.09.670Get rights and content
Under an Elsevier user license
open archive

Cited by (0)